30.01
price down icon0.66%   -0.20
after-market Dopo l'orario di chiusura: 30.01
loading

Xoma Royalty Corp Borsa (XOMA) Ultime notizie

pulisher
Nov 16, 2024

Short Interest in XOMA Co. (NASDAQ:XOMA) Drops By 23.5% - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

XOMA Co. (NASDAQ:XOMA) Sees Large Decrease in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Xoma CEO Owen Hughes sells $655,335 in stock - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 - Investing.com

Nov 13, 2024
pulisher
Nov 11, 2024

What Makes XOMA Royalty (XOMA) a New Buy Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Recent Activities - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is HC Wainwright's Forecast for XOMA FY2025 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

Nov 10, 2024
pulisher
Nov 09, 2024

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

XOMA Royalty’s Third Quarter 2024 Financial Insights - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

XOMA Royalty: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - ForexTV.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xoma reports Q3 EPS ($1.59), consensus (44c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World

Nov 05, 2024
pulisher
Oct 30, 2024

XOMA Royalty Corporation's (NASDAQ:XOMA) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Simply Wall St

Oct 30, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 - Investing.com India

Oct 29, 2024
pulisher
Oct 27, 2024

XOMA’s (XOMA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October - Defense World

Oct 26, 2024
pulisher
Oct 23, 2024

Twist Bioscience enters into purchase agreement with XOMA Royalty - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

XOMA (NASDAQ:XOMA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

XOMA Royalty Corporation Acquires 50% of Twist's Existing Royalty and Milestone Economics for $15 Million - Marketscreener.com

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and - GlobeNewswire

Oct 22, 2024
pulisher
Oct 22, 2024

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - The Bakersfield Californian

Oct 22, 2024
pulisher
Oct 21, 2024

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year - Yahoo Finance

Oct 21, 2024
pulisher
Oct 19, 2024

Ellsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA) - MarketBeat

Oct 19, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 15, 2024

XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties (NASDAQ:XOMA) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 09, 2024

XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 01, 2024

XOMA Co. (NASDAQ:XOMA) is Stonepine Capital Management LLC’s 6th Largest Position - Defense World

Oct 01, 2024
pulisher
Sep 29, 2024

PIMCO Strategic Income Fund, XOMA Corporation, Another 2 Companies Have A High Estimated Dividend Yield - Via News Agency

Sep 29, 2024
pulisher
Sep 29, 2024

Rhumbline Advisers Raises Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91 - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.91 - MarketBeat

Sep 28, 2024
pulisher
Sep 24, 2024

XOMA Co. (NASDAQ:XOMAO) Announces $0.52 Quarterly Dividend - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

XOMA shares hold as analyst reiterates Buy rating post-FDA nod - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMAOXOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Sep 23, 2024

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. - GlobeNewswire

Sep 23, 2024
pulisher
Sep 23, 2024

Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC - TipRanks

Sep 23, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):